Management of Elevated INR in Patients with Malabsorption

Introduction to Malabsorption and INR Management

The American Society of Hematology notes that over-the-counter vitamin K formulations have variable quality and actual content, which could compound absorption issues in patients with malabsorption, and pharmaceutical-grade oral vitamin K requires intact gut function to work 1, 2

For patients without malabsorption and INR 4.5-10 without bleeding, withholding warfarin alone without vitamin K is recommended 2, 3
For patients without malabsorption and INR >10 without bleeding, oral vitamin K 2-2.5 mg reduces the risk of INR >5 by day 3 (11.1% vs 46.7% with warfarin withdrawal alone) 3
For patients with active malabsorption, skipping oral vitamin K entirely and using subcutaneous or intravenous vitamin K is recommended, with monitoring of INR every 1-2 days initially 3

High-dose vitamin K (>5 mg) should be avoided as it can cause warfarin resistance lasting up to one week, complicating subsequent anticoagulation management 4
For patients with mechanical heart valves and very high INR, intravenous vitamin K should be avoided due to thrombosis risk; instead, allowing gradual INR decline with warfarin cessation, or using fresh-frozen plasma if INR >10 is recommended 3